These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
338 related articles for article (PubMed ID: 19465936)
1. Aryl hydrocarbon receptor inhibition downregulates the TGF-beta/Smad pathway in human glioblastoma cells. Gramatzki D; Pantazis G; Schittenhelm J; Tabatabai G; Köhle C; Wick W; Schwarz M; Weller M; Tritschler I Oncogene; 2009 Jul; 28(28):2593-605. PubMed ID: 19465936 [TBL] [Abstract][Full Text] [Related]
2. An imbalance between Smad and MAPK pathways is responsible for TGF-beta tumor promoting effects in high-grade gliomas. Nickl-Jockschat T; Arslan F; Doerfelt A; Bogdahn U; Bosserhoff A; Hau P Int J Oncol; 2007 Feb; 30(2):499-507. PubMed ID: 17203233 [TBL] [Abstract][Full Text] [Related]
3. RNA interference targeting transforming growth factor-beta enhances NKG2D-mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates tumorigenicity in vivo. Friese MA; Wischhusen J; Wick W; Weiler M; Eisele G; Steinle A; Weller M Cancer Res; 2004 Oct; 64(20):7596-603. PubMed ID: 15492287 [TBL] [Abstract][Full Text] [Related]
4. SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo. Uhl M; Aulwurm S; Wischhusen J; Weiler M; Ma JY; Almirez R; Mangadu R; Liu YW; Platten M; Herrlinger U; Murphy A; Wong DH; Wick W; Higgins LS; Weller M Cancer Res; 2004 Nov; 64(21):7954-61. PubMed ID: 15520202 [TBL] [Abstract][Full Text] [Related]
5. The aryl hydrocarbon receptor links integrin signaling to the TGF-β pathway. Silginer M; Burghardt I; Gramatzki D; Bunse L; Leske H; Rushing EJ; Hao N; Platten M; Weller M; Roth P Oncogene; 2016 Jun; 35(25):3260-71. PubMed ID: 26500056 [TBL] [Abstract][Full Text] [Related]
6. Microglia-derived TGF-beta as an important regulator of glioblastoma invasion--an inhibition of TGF-beta-dependent effects by shRNA against human TGF-beta type II receptor. Wesolowska A; Kwiatkowska A; Slomnicki L; Dembinski M; Master A; Sliwa M; Franciszkiewicz K; Chouaib S; Kaminska B Oncogene; 2008 Feb; 27(7):918-30. PubMed ID: 17684491 [TBL] [Abstract][Full Text] [Related]
7. Interaction between the aryl hydrocarbon receptor and transforming growth factor-beta signaling pathways: evidence of an asymmetrical relationship in rat granulosa cells. Bussmann UA; Barañao JL Biochem Pharmacol; 2008 Oct; 76(9):1165-74. PubMed ID: 18786509 [TBL] [Abstract][Full Text] [Related]
8. LTBP-1 blockade in dioxin receptor-null mouse embryo fibroblasts decreases TGF-beta activity: Role of extracellular proteases plasmin and elastase. Gomez-Duran A; Mulero-Navarro S; Chang X; Fernandez-Salguero PM J Cell Biochem; 2006 Feb; 97(2):380-92. PubMed ID: 16187295 [TBL] [Abstract][Full Text] [Related]
16. Regulation of aryl hydrocarbon receptor activity in porcine cumulus-oocyte complexes in physiological and toxicological conditions: the role of follicular fluid. Nestler D; Risch M; Fischer B; Pocar P Reproduction; 2007 May; 133(5):887-97. PubMed ID: 17616719 [TBL] [Abstract][Full Text] [Related]
17. Effects of RNAi-mediated Smad4 silencing on growth and apoptosis of human rhabdomyosarcoma cells. Ye L; Zhang H; Zhang L; Yang G; Ke Q; Guo H; Bu H Int J Oncol; 2006 Nov; 29(5):1149-57. PubMed ID: 17016646 [TBL] [Abstract][Full Text] [Related]
18. Immunosuppression and transforming growth factor-beta in glioblastoma. Preferential production of transforming growth factor-beta 2. Bodmer S; Strommer K; Frei K; Siepl C; de Tribolet N; Heid I; Fontana A J Immunol; 1989 Nov; 143(10):3222-9. PubMed ID: 2809198 [TBL] [Abstract][Full Text] [Related]
19. Modulation of TGF-beta activity by latent TGF-beta-binding protein 1 in human malignant glioma cells. Tritschler I; Gramatzki D; Capper D; Mittelbronn M; Meyermann R; Saharinen J; Wick W; Keski-Oja J; Weller M Int J Cancer; 2009 Aug; 125(3):530-40. PubMed ID: 19431147 [TBL] [Abstract][Full Text] [Related]
20. Altered cell cycle control at the G(2)/M phases in aryl hydrocarbon receptor-null embryo fibroblast. Elizondo G; Fernandez-Salguero P; Sheikh MS; Kim GY; Fornace AJ; Lee KS; Gonzalez FJ Mol Pharmacol; 2000 May; 57(5):1056-63. PubMed ID: 10779392 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]